Celexa and Stelara drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Celexa (citalopram hydrobromide) and Stelara (ustekinumab). Common drug interactions include abdominal distension among females and weight increased among males.

The phase IV clinical study analyzes what interactions people have when they take Celexa and Stelara. It is created by eHealthMe based on reports of 81 people who take the same drugs from the FDA, and is updated regularly.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.

What is Stelara?

Stelara has active ingredients of ustekinumab. It is often used in psoriasis. eHealthMe is studying from 96,053 Stelara users. Check the latest studies of Stelara.

On Jul, 07, 2026

81 people who take Celexa and Stelara together, and have interactions are studied.

What are the common drug interactions of Celexa and Stelara, by gender? *:

female:

Abdominal distension
Cardiac flutter (abnormal heart rhythm)
Crying
Death
Dehydration (dryness resulting from the removal of water)
Drug resistance (reduction in effectiveness of a drug)
Dyspnoea (difficult or laboured respiration)
Erythema of eyelid (redness of the eyelid)
Eye swelling
Feeling hot

male:

Weight increased
Drug ineffective
Keratomileusis
Adverse drug reaction
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Depressed mood
Diarrhoea
Essential hypertension (primary hypertension)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hepatic enzyme increased

What are the common drug interactions of Celexa and Stelara, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Hepatic enzyme increased
Impaired healing
Limb injury
Wound

20-29:

Back pain
Dizziness
Nausea (feeling of having an urge to vomit)
Rhinitis allergic (inflammation of the nasal airways due to allergy)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Mobility decreased (ability to move is reduced)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Thyroid mass
Abdominal discomfort

30-39:

Weight increased
Abdominal distension
Injection site discolouration
Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site)
Pancreatitis acute (sudden inflammation of pancreas)
Sinusitis (inflammation of sinus)
Dysphagia (a condition in which swallowing is difficult or painful)
Lymphadenopathy (disease or enlargement of lymph nodes)
Tonsillar neoplasm (cancer or tumour of tonsil)
Depressed mood

40-49:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Arthropathy
Blood bilirubin increased
Drug effect decreased
Medical device complication
Post procedural complication
Adverse drug reaction
Essential hypertension (primary hypertension)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)

50-59:

Drug ineffective
Blood glucose increased
Blood triglycerides increased
Lipids increased (excess lipid in body)
Nail injury
Post procedural infection
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Headache (pain in head)
Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
Adverse event

60+:

Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Skin exfoliation (removal of the oldest dead skin cells)
Arthralgia (joint pain)
Drug intolerance (drug sensitivity)
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Muscle spasms (muscle contraction)
Vomiting
Contusion (a type of hematoma of tissue in which capillaries)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 23 people, 28.40%
Stress And Anxiety: 13 people, 16.05%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 11 people, 13.58%
High Blood Cholesterol: 5 people, 6.17%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 6.17%

* Approximation only. Some reports may have incomplete information.

Do you take Celexa and Stelara?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously